Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities URGN - UroGen Pharma Ltd.
195 M
LAST VALUE
41.55%
2 YEAR CAGR
3.33%
5 YEAR CAGR
44.36%
10 YEAR CAGR